-

FeNO Plan on a Page

Are you struggling to persuade your ICB to fund FeNO testing? Unsure when to use it - or when not to? You’re not alone.

Register now
Woman wearing headphones, watching webinar on laptop

Join Dr Sanjeev Rana and Dr Katherine Hickman on Wednesday 30th April from 19:00 for a focused, practical session offering clear, evidence-based guidance on when to use FeNO testing to support asthma diagnosis.

We’ll also walk you through creating a compelling "Plan on a Page" to make the financial case for FeNO - even in times of tight budgets.

In this session, we will:

  • Address common barriers
  • Align recommendations with national guidance
  • Help you build confidence in implementing FeNO testing across primary care

During this session you will be able to ask Sanjeev and Katherine any questions you may have on FeNO and making your case for it.

Clinical Area
Asthma Respiratory tests and investigations
Derivation
PCRS Produced / Collaboration

Speakers

  • Katherine Hickman

    photo of Katherine HickmanKatherine qualified from Leeds University in 2000. She originally did a Medicine Rotation acquiring her MRCP before settling into General Practice. She is a GP Partner in Bradford. Katherine is the Respiratory Lead for West Yorkshire ICB, Primary Care Clinical Lead for the National Respiratory Audit Programme (NRAP), and Chair of PCRS. Outside of work she enjoys cooking, baking, yoga, and outdoor swimming and has recently rediscovered her love for singing and joined a choir.

  • Sanjeev Rana

    photo of Sanjeev RanaDr. Sanjeev Rana is a full time General Practitioner, GP trainer, Clinical Commissioner, Medical Director, and Respiratory GPwER working in West Essex.
    He graduated from the Imperial School of Medicine and Technology in 1995 and qualified as a General Practitioner in 1998. His interests include Respiratory, dermatology, skin surgery and urgent care. He has a keen interest in population-based healthcare, applying international healthcare models to local service delivery, applying risk stratification tools to chronic disease management to optimise healthcare utilisation, developing the NHS workforce, and understanding what value means to the NHS.

A PCRS Consensus: FeNO testing for asthma diagnosis

The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs. 

Guide to FeNO Testing

In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease.  She discusses the advantages and limitations of this test. 

FeNO for the diagnosis and management of asthma

Resources from the Academic Health Science Network (AHSN) Programme

You may also be interested in...

Join PCRS Today

Become part of the UK's largest network of dedicated respiratory professionals working in primary, community and integrated care settings.

FeNO

The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.